1,25-dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine

被引:46
作者
Kutuzova, Galina D. [1 ]
DeLuca, Hector F. [1 ]
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
关键词
vitamin D and intestine; VDR; microarrays; cytochrome P450 (CYP); phase I and phase II biotransformation;
D O I
10.1016/j.taap.2006.10.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 alpha,25-Dihydroxyvitamin D-3 (1,25-(OH)(2)D-3) the biologically active form of vitamin D-3, not only plays a major role in mammalian calcium and phosphorous homeostasis but also exerts pleiotropic effects on cell proliferation, differentiation and the immune system. Further, vitamin D is believed to play a significant role in the prevention of colon, prostate, and breast cancer and in reducing the risk of autoimmune diseases. To gain insight into the mechanism whereby vitamin D can have such diverse actions, we have employed microarray technology. We studied the effect of a single dose of 1,25-(OH)(2)D-3 on gene expression in the intestine of vitamin D-deficient rats. Within 6 h, 1,25-(OH)(2)D-3 stimulates the expression of several phase I and phase II biotransformation genes. There is also an increased expression of antioxidant genes. These results support the idea that vitamin D is a significant factor in detoxification and protection against environmental toxins. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 50 条
[31]  
McDonald T. J., 1989, STUDIES AM POLITICAL, V3, P3
[32]   C-elegans DAF-12, nuclear hormone receptors and human longevity and disease at old age [J].
Mooijaart, SP ;
Brandt, BW ;
Baldal, EA ;
Pijpe, J ;
Kuningas, M ;
Beekman, M ;
Zwaan, BJ ;
Slagboom, PE ;
Westendorp, RGJ ;
van Heemst, D .
AGEING RESEARCH REVIEWS, 2005, 4 (03) :351-371
[33]   Noncalcemic actions of vitamin D receptor ligands [J].
Nagpal, S ;
Na, SQ ;
Rathnachalam, R .
ENDOCRINE REVIEWS, 2005, 26 (05) :662-687
[34]   Regulatory mechanisms controlling gene expression mediated by the antioxidant response element [J].
Nguyen, T ;
Sherratt, PJ ;
Pickett, CB .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :233-260
[35]  
Obach RS, 2001, DRUG METAB DISPOS, V29, P347
[36]   Eight cytochrome P450s catalyze vitamin D metabolism [J].
Ohyama, Y ;
Yamasaki, T .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :3007-3018
[37]   Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors [J].
Rendic, S ;
DiCarlo, FJ .
DRUG METABOLISM REVIEWS, 1997, 29 (1-2) :413-580
[38]   Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes [J].
Rushmore, TH ;
Kong, ANT .
CURRENT DRUG METABOLISM, 2002, 3 (05) :481-490
[39]   Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor [J].
Shimizu, Y ;
Nakatsuru, Y ;
Ichinose, M ;
Takahashi, Y ;
Kume, H ;
Mimura, J ;
Fujii-Kuriyama, Y ;
Ishikawa, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :779-782
[40]   Orphan receptor promiscuity in the induction of cytochromes P450 by xenobiotics [J].
Smirlis, D ;
Muangmoonchai, R ;
Edwards, M ;
Phillips, IR ;
Shephard, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12822-12826